Search Within

Breast Medicine Service

Formats
  1. Journal Article (2206)
  2. Meeting Abstract (1680)
  3. Review (83)
  4. Book Section (69)
  5. Editorial (44)
  6. Conference Paper (28)
  7. Guidelines (27)
  8. Correspondence (16)
  9. Miscellaneous (12)
  10. Research Letter (11)
  11. Book Whole (5)
Groups
  1. Department of Medicine (4181)
  2. Solid Tumor Oncology Division (4181)
  3. Survivorship Research (2373)
  4. GSK Faculty (1516)
  5. Population Sciences Research Program (1369)
  6. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (1144)

More Groups

People
  1. Clifford Hudis (906)
  2. Larry Norton (762)
  3. Mark Robson (684)
  4. Neal Rosen (427)
  5. Andrew Seidman (319)
  6. Kenneth Offit (300)

More People

Years
  1. 2025 (130)
  2. 2024 (195)
  3. 2023 (168)
  4. 2022 (219)
  5. 2021 (236)
  6. 2020 (250)

More Years

Publications
  1. Journal of Clinical Oncology (828)
  2. Cancer Research (481)
  3. Breast Cancer Research and Treatment (170)
  4. Annals of Oncology (159)
  5. Clinical Cancer Research (132)
  6. Cancer (78)

More Publications

Publishers
  1. American Society of Clinical Oncology (880)
  2. American Association for Cancer Research (755)
  3. Springer (332)
  4. Elsevier Inc. (308)
  5. Oxford University Press (282)
  6. Nature Publishing Group (276)

More Publishers

Results (4181)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • TBCRC009: A multicenter phase II study of cisplatin or carboplatin for metastatic triple-negative breast cancer and evaluation of p63/p73 as a biomarker of response
    Meeting Abstract

    Isakoff, S. J.; Goss, P. E.; Mayer, E. L.; Traina, T. A.; Carey, L. A.; Krag, K.; Rugo, H. S.; Liu, M. C.; Stearns, V.; Come, S. E.; more...
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Sorafenib (SOR) plus chemotherapy (CRx) for patients (pts) with advanced (adv) breast cancer (BC) previously treated with bevacizumab (BEV)
    Meeting Abstract

    Hudis, C.; Tauer, K. W.; Hermann, R. C.; Makari-Judson, G.; Isaacs, C.; Beck, J. T.; Kaklamani, V. G.; Stepanski, E. J.; Rugo, H. S.; Wang, W.; more...
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Hepatic arterial infusion (HAI) in the treatment of breast cancer with liver metastases (BCLM) in patients (pts) who progressed after hormonal and systemic chemotherapy (CTx)
    Meeting Abstract

    Herran, L. A.; Jhaveri, K. L.; Seidman, A. D.; Patel, D.; Gewirtz, A. N.; Kemeny, N. E.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • TBCRC 011: Targeting the androgen receptor (AR) for the treatment of AR+/ER-/PR-metastatic breast cancer (MBC)
    Meeting Abstract

    Gucalp, A.; Tolaney, S. M.; Isakoff, S. J.; Ingle, J. N.; Liu, M. C.; Carey, L. A.; Blackwell, K. L.; Rugo, H. S.; Nabell, L.; Abbruzzi, A.; more...
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • A phase I study of the AKT inhibitor (MK-2206) with concurrent trastuzumab and lapatinib in patients with HER2-positive solid tumors
    Meeting Abstract

    Han, H. S.; Swanton, C.; Janjigian, Y. Y.; Sutherland, S. C.; Chandarlapaty, S.; Lehman, R.; Hamilton, N.; Knowles, J.; Lee, R.; Yan, L.; more...
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Combined inhibition of mTORC1 with temsirolimus and HER2 with neratinib: A phase I study in patients with metastatic HER2-amplified breast cancer
    Meeting Abstract

    Gajria, D.; King, T. A.; Pannu, H.; Sakr, R.; Seidman, A. D.; Syldor, A.; Patil, S.; Maybody, M.; Norton, L.; Rosen, N.; more...
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • TBCRC 019: An open-label, randomized, phase II trial of nanoparticle albumin-bound paclitaxel with or without the anti-death receptor 5 (DR5) monoclonal antibody tigatuzumab in patients with metastatic, triple-negative (ER, PR, and HER2-negative) breast cancer
    Meeting Abstract

    Forero-Torres, A.; Lin, N. U.; Liu, M. C.; Rugo, H. S.; Puhalla, S.; Nanda, R.; Mayer, I. A.; Storniolo, A. M.; Traina, T. A.; Hayes, D. F.; more...
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • A pilot study of vaccination with sialyl Lewis(a) (sLe(a))-keyhole limpet hemocyanin (KLH) conjugate plus the immunologic adjuvant QS-21 in metastatic breast cancer patients (pts)
    Meeting Abstract

    Diab, A.; Ragupathi, G.; Scholz, W. W.; Panageas, K.; Hudis, C.; Livingston, P. O.; Gilewski, T.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Presentation of breast cancer (BC) diagnosed at or before 30 years of age: Implications for screening women at hereditary risk
    Meeting Abstract

    de Alcantara Filho, P.; King, T. A.; Morris, E. A.; Hudis, C.; Robson, M. E.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Long-term cardiac safety and outcomes of dose-dense (dd) doxorubicin and cyclophosphamide (AC) followed by paclitaxel (T) and trastuzumab (H) with and without lapatinib (L) in patients (pts) with early breast cancer (BC)
    Meeting Abstract

    Dang, C. T.; Morris, P. G.; Patil, S.; Chen, C.; Abbruzzi, A.; Lehman, R.; Steingart, R.; Norton, L.; Hudis, C.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save